The Danish venture financing remained stable from 2013 to 2015 at around USD 85m. However, private financing of Biotech companies showed a large intercompany variation. Danish LS Trend Analysis 2015 Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new leads, licensing opportunities and management details. Get started now Learn more
Year: 2015
Sweden Life Sciences Trend Analysis 2015
After the best venture financing of Swedish Biotechnology Company of the last 5 years in 2014, the venture financing goes back to previous level in 2015 to date. The pipeline is maturing and renewing at the same time, with the number of products in phase II similar to the number of product in preclinical studies. … Continue reading Sweden Life Sciences Trend Analysis 2015
European Life Sciences Report – Site Selection for Life Sciences Companies
Zurich / Singapore, November 2015 – Venture Valuation together with KPMG has released its 2015 Report on “Site Selection for Life Sciences companies in Europe”. The report looks across the European Life Sciences landscape, analysing and comparing 14 European countries. The report looks at the strength of Biotechnology, Medical Technology and Pharma. This second edition … Continue reading European Life Sciences Report – Site Selection for Life Sciences Companies
Biotechgate down-under – New life sciences directory for Australia
Zurich / Melbourne, November 2015: Venture Valuations Biotechgate and AusBiotech, the Australian Biotech Industry Association, have entered into an agreement to create a comprehensive directory of Australian biotechnology and life science companies and extend the network and reach of Biotechgate. The Australian Life Sciences Directory will have a standalone web address and will also be … Continue reading Biotechgate down-under – New life sciences directory for Australia
German Life Sciences Trend Analysis 2015
Venture financing of German biotechnology companies drop to normal levels in 2015 following the best year for venture financing in the last 5 years. In the first half of 2015, close to USD 90m was raised in 5 financing rounds. German LS Trend Analysis 2015 Looking for your next Biotech or Medtech partner? Use … Continue reading German Life Sciences Trend Analysis 2015
Site Selection for Life Sciences Companies in Europe
2015 edition The “Site Selection for Life Sciences companies in Europe” report analyzes the structure of the European life sciences landscape and looks at the strength of the Biotech, Medtech and Pharma industry of the specific market. The 2015 edition of the report includes a comparison of the following countries: Austria, Belgium, Denmark, France, Finland, … Continue reading Site Selection for Life Sciences Companies in Europe
French Life Sciences Trend Analysis 2015
Venture financing of French biotech companies is setting out to be very strong in the second half of this year, as it has already surpassed the levels seen in the second half of 2013 and 2014 respectively. France LS Trend Analysis 2015 Looking for your next Biotech or Medtech partner? Use Biotechgate to identify … Continue reading French Life Sciences Trend Analysis 2015
Life Science Trend Analysis 2015 for Italy
Venture financing of Italian biotech companies is picking up once again. In the first half of 2015 alone, USD 17.8M was raised, which is making it the second best half in 5 years. Life science venture financing was somewhat disappointing in 2014 compared to 2013 where USD 8.15M and USD 20.38M was raised respectively. Click … Continue reading Life Science Trend Analysis 2015 for Italy
Life Science Trend Analysis 2015 for Austria
With three rounds of financing and a combined value of USD 6.7M, 2014 proved to be a weak year for biotech financing in Austria. 2015 is set to look very different, as Austrian biotech financing gains momentum with an impressive USD 50M financing round to Nabriva to start off the first half of 2015. Click … Continue reading Life Science Trend Analysis 2015 for Austria
Identifying products on Biotechgate
Looking to identify new products to in-license or to acquire, can be a time consuming task. The Biotechgate database provides details of over 36,000 companies worldwide and more than 45,000 products. These 45,000+ products are categorised by their therapeutic target and sub sectors. You can also select products that are available for licensing. Biotechgate’s simple … Continue reading Identifying products on Biotechgate